---
created: 2025-04-13
updated: 2025-04-13T10:52
id: u*MPOcvxv^
specialty: gastro
specialty_id: 11
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::!flag-these-cards::temporary
  - "source/ak-step1-v11:": 
  - theme/b&b::09-gi::03-clinical::16-gastrointestinal-pharm
  - "source/ak-step1-v11:": 
  - theme/firstaid::09-gastrointestinal::05-pharm::03-proton-pump-inhibitors
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::11-gastrointestinal
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::11-gastrointestinal::02-proton-pump-inhibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::09-gi::proton-pump-inhibitors-(ppis)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::05-gi-&-endocrine::01-gi::03-h2-receptor-blockers,-ppis
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::19000-19999::19343
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::gi::pharm"
type: flashcard
---

# Question
Decreased magnesium absorption as a result of proton pump inhibitors (PPIs) may cause **hypomagnesemia**

---

# Answer
Chronic PPI use protects exogenously administered lipase and enhances fat absorption in patients dependent on pancreatic enzyme replacement therapy.